Stockscreener 앱 받기
4.73
0.63%
-0.03
시간 외 거래:
4.76
0.03
+0.63%
Edesa Biotech Inc 주식(EDSA)의 최신 뉴스
Edesa Biotech Stock Price Forecast. Should You Buy EDSA? - StockInvest.us
Stonepine Capital Management, LLC Expands Edesa Biotech Inc (EDS - GuruFocus
Insider share moves at Edesa Biotech (EDSA) detailed in new SEC filing - Stock Titan
Velan Capital Investment Management LP Expands Edesa Biotech Inc (EDSA) Stake - GuruFocus
EDSA Should I Buy - Intellectia AI
Stonepine group discloses sub-10% Edesa Biotech (NASDAQ: EDSA) position - Stock Titan
Velan Capital lifts Edesa Biotech (EDSA) stake to 9.99% with warrant leverage - Stock Titan
Edesa Biotech (NASDAQ: EDSA) major holder's multi-million-share stake detailed - Stock Titan
Edesa Biotech Enters Underwriting Deal With Guggenheim for $23.1M Equity Offering - TradingView
EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits
Edesa Biotech Prices $25 Million Stock-and-Warrant Offering to Fund Drug Pipeline - finance.biggo.com
Edesa Biotech Shares Tumble 13% on $25 Million Equity Offering - finance.biggo.com
Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits
Edesa (EDSA) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session; Share Move - vinanet.vn
Edesa Biotech Stock Sinks After Fresh Capital Raise - TradingView
Edesa Biotech raises USD 25m to fuel vitiligo Phase II - AllSci
Edesa Biotech Raises $25 Million in Public Offering to Advance Immuno-Inflammatory Pipeline - TipRanks
Edesa Biotech prices $25M public offering at $5.50 per share By Investing.com - Investing.com Australia
Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com Australia
Edesa Biotech Announces Pricing of $25.0 Million Public Offering - Yahoo Finance
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com Nigeria
Edesa Biotech Launches Public Offering of Common Shares, Warrants - marketscreener.com
Edesa Biotech Launches Public Offering to Fund Immuno-Inflammatory Pipeline - tipranks.com
Edesa Biotech launches public offering of common shares - Investing.com
Edesa Biotech stock tumbles on public offering launch - Investing.com
Edesa Biotech Announces Proposed Public Offering of Common Shares and Warrants - Quiver Quantitative
Edesa Biotech Announces Proposed Public Offering - The Manila Times
Edesa Biotech(EDSA) Stock Options Chain | Quotes & News - Moomoo
Edesa Biotech Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
EDSA Q2 2026 Earnings: EPS Misses Consensus by 84.77% Despite Shares Rallying 5.61%Earnings Volatility Report - vinanet.vn
Brokers Set Expectations for Edesa Biotech FY2026 Earnings - MarketBeat
EDSA Q2 2026 Earnings: Wider-than-Expected Loss Amid Clinical-Stage SpendingShare Dilution Risk - vinanet.vn
EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits
Edesa Biotech (NASDAQ:EDSA) Posts Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat
Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K EDESA BIOTECH For: 13 August By Investing.com - Investing.com South Africa
Edesa Biotech Q3 loss widens 140% to $5.4M on rising R&D spend - scanx.trade
Edesa Biotech (EDSA) loss widens to $11.9M as R&D surges and cash tightens - Stock Titan
Edesa Reports $5.4 Million Q3 Loss as EB06 Phase 2 Site Activation Begins - Quiver Quantitative
Edesa Starts Activating First Vitiligo Trial Sites as Enrollment Nears - Stock Titan
Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Edesa Biotech (EDSA) Rallies 5.34% as Shares Test Key Resistance at $5.80Volatility Breakout Picks - dars.gov.et
Edesa Biotech (EDSA) Edges Up 2.28% to $5.39 as Clinical-Stage Biotech Draws InterestRisk Reversal - dars.gov.et
Edesa Biotech (EDSA) to Post Earnings on Monday - MarketBeat
Edesa Biotech Inc (EDSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EDSA Q2 2026 Earnings: Wider Loss and 84.77% Negative Surprise Spotlight Pre-Revenue R&D Outlays - vinanet.vn
EDSA Q3'26 Earnings: EPS estimate is (0.43) USD - TradingView
Edesa Biotech (NASDAQ: EDSA) CEO receives 5,324 restricted share units - Stock Titan
EDSA Q3'26 Earnings: revenue estimate is 0 USD - TradingView
Edesa Biotech Inc (EDSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Edesa Biotech Inc (EDSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Edesa Biotech Inc (EDSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edesa Biotech Inc (EDSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Edesa Biotech Inc (EDSA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Edesa Biotech Inc (EDSA) Income Statement - TradingKey
0.86%
0.31%
자본화:
|
볼륨(24시간):